LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs
- 1 October 1998
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 359 (2-3) , 103-109
- https://doi.org/10.1016/s0014-2999(98)00632-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Competitive NMDA-Receptor Antagonists, LY 235959 and LY 233053, Enhance the Protective Efficacy of Various Antiepileptic Drugs Against Maximal Electroshock-Induced Seizures in MiceEpilepsia, 1996
- Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in miceEuropean Journal of Pharmacology, 1995
- The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepilepticsEuropean Journal of Pharmacology, 1995
- Glutamate antagonists have different effects on spontaneous locomotor activity in ratsPharmacology Biochemistry and Behavior, 1994
- Competitive antagonist of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in miceEuropean Journal of Pharmacology, 1993
- Phosphonic analogues of excitatory amino acids raise the threshold for maximal electroconvulsions in miceNeuroscience Research, 1985
- Effects of excitatory amino-acid antagonists on the anticonvulsant action of phenobarbital or diphenylhydanton in miceEuropean Journal of Pharmacology, 1984
- Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acidEuropean Journal of Pharmacology, 1982
- Anticonvulsant Action of Excitatory Amino Acid AntagonistsScience, 1982
- Une nouvelle méthode simple pour explorer l’action «tranquillisante»: le test de la cheminéePharmacology, 1960